pyridoxine has been researched along with thiotepa in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blackard, C; Byar, D | 1 |
Mount, BM | 1 |
Ingargiola, GB; Pavone-Macaluso, M; Tripi, M | 1 |
Gallo, PP; Kianifard, F | 1 |
Lindsey, JK | 1 |
Chen, F; Chen, K | 1 |
2 review(s) available for pyridoxine and thiotepa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The prophylaxis of nonindustrial urothelial tumours.
Topics: Analgesics; Ascorbic Acid; Coffee; Female; Humans; Male; Papilloma; Pyridoxine; Sex Factors; Smoking; Sweetening Agents; Thiotepa; Urethral Stricture; Urinary Bladder Neoplasms; Urinary Tract Infections; Urination Disorders | 1973 |
2 trial(s) available for pyridoxine and thiotepa
Article | Year |
---|---|
Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
Topics: Administration, Oral; Administration, Topical; Clinical Trials as Topic; Drug Evaluation; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Placebos; Pyridoxine; Thiotepa; Urinary Bladder Neoplasms | 1977 |
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Multi-Institutional Systems; Neoplasm Recurrence, Local; Prognosis; Pyridoxine; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
4 other study(ies) available for pyridoxine and thiotepa
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Poisson regression analysis in clinical research.
Topics: Epilepsy; Humans; Mathematical Computing; Models, Biological; Placebos; Poisson Distribution; Pyridoxine; Randomized Controlled Trials as Topic; Regression Analysis; Thiotepa; Urinary Bladder Neoplasms | 1995 |
A general family of distributions for longitudinal dependence with special reference to event histories.
Topics: Antineoplastic Agents, Alkylating; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Longitudinal Studies; Models, Biological; Neoplasm Recurrence, Local; Pyridoxine; Randomized Controlled Trials as Topic; Statistical Distributions; Thiotepa; Urinary Bladder Neoplasms | 2001 |
Case-cohort analysis of clusters of recurrent events.
Topics: Cluster Analysis; Cohort Studies; Computer Simulation; Humans; Likelihood Functions; Neoplasm Recurrence, Local; Proportional Hazards Models; Pyridoxine; Thiotepa; Urinary Bladder Neoplasms | 2014 |